Dopamine-inhibited POMCDrd2+ neurons in the ARC acutely regulate feeding and body temperature.

Autor: Gaziano I; Neuronal Control of Metabolism group, Max Planck Institute for Metabolism Research, Cologne, Germany.; Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center of Molecular Medicine Cologne (CMMC) and., Corneliussen S; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center of Molecular Medicine Cologne (CMMC) and.; Institute for Zoology, Faculty of Mathematics and Natural Sciences, University of Cologne, Germany., Biglari N; Neuronal Control of Metabolism group, Max Planck Institute for Metabolism Research, Cologne, Germany.; Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center of Molecular Medicine Cologne (CMMC) and., Neuhaus R; Neuronal Control of Metabolism group, Max Planck Institute for Metabolism Research, Cologne, Germany.; Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center of Molecular Medicine Cologne (CMMC) and., Shen L; Neuronal Control of Metabolism group, Max Planck Institute for Metabolism Research, Cologne, Germany.; Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center of Molecular Medicine Cologne (CMMC) and., Sotelo-Hitschfeld T; Neuronal Control of Metabolism group, Max Planck Institute for Metabolism Research, Cologne, Germany.; Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center of Molecular Medicine Cologne (CMMC) and., Klemm P; Neuronal Control of Metabolism group, Max Planck Institute for Metabolism Research, Cologne, Germany.; Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center of Molecular Medicine Cologne (CMMC) and., Steuernagel L; Neuronal Control of Metabolism group, Max Planck Institute for Metabolism Research, Cologne, Germany.; Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center of Molecular Medicine Cologne (CMMC) and., De Solis AJ; Neuronal Control of Metabolism group, Max Planck Institute for Metabolism Research, Cologne, Germany.; Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center of Molecular Medicine Cologne (CMMC) and., Chen W; Neuronal Control of Metabolism group, Max Planck Institute for Metabolism Research, Cologne, Germany.; Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center of Molecular Medicine Cologne (CMMC) and., Wunderlich FT; Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center of Molecular Medicine Cologne (CMMC) and.; Obesity and Cancer group, Max Planck Institute for Metabolism Research, Cologne, Germany., Kloppenburg P; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center of Molecular Medicine Cologne (CMMC) and.; Institute for Zoology, Faculty of Mathematics and Natural Sciences, University of Cologne, Germany., Brüning JC; Neuronal Control of Metabolism group, Max Planck Institute for Metabolism Research, Cologne, Germany.; Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD) and Center of Molecular Medicine Cologne (CMMC) and.; National Center for Diabetes Research (DZD), Neuherberg, Germany.

Publikováno v: JCI insight [JCI Insight] 2022 Nov 08; Vol. 7 (21). Date of Electronic Publication: 2022 Nov 08.

New roles for dopamine D 2 and D 3 receptors in pancreatic beta cell insulin secretion.

Autor: Farino ZJ; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA., Morgenstern TJ; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Maffei A; Division of Endocrinology, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Quick M; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA., De Solis AJ; Division of Molecular Genetics, Naomi Berrie Diabetes Center, Columbia University, New York, NY, USA., Wiriyasermkul P; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Freyberg RJ; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA., Aslanoglou D; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA., Sorisio D; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA., Inbar BP; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Free RB; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Donthamsetti P; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Mosharov EV; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.; Department of Neurology, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Kellendonk C; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.; Department of Pharmacology, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Schwartz GJ; Departments of Medicine and Neuroscience, Albert Einstein College of Medicine, Bronx, NY, USA., Sibley DR; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Schmauss C; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA., Zeltser LM; Division of Molecular Genetics, Naomi Berrie Diabetes Center, Columbia University, New York, NY, USA.; Department of Pathology and Cell Biology, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Moore H; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Integrative Neuroscience, New York State Psychiatric Institute, New York, NY, USA., Harris PE; Division of Endocrinology, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Javitch JA; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.; Department of Pharmacology, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Freyberg Z; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA. freyberg@pitt.edu.; Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA, USA. freyberg@pitt.edu.

Publikováno v: Molecular psychiatry [Mol Psychiatry] 2020 Sep; Vol. 25 (9), pp. 2070-2085. Date of Electronic Publication: 2019 Jan 09.

Ciliary gene RPGRIP1L is required for hypothalamic arcuate neuron development.

Autor: Wang L; Naomi Berrie Diabetes Center and Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York, USA., De Solis AJ; Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany., Goffer Y; Naomi Berrie Diabetes Center & Division of Molecular Genetics, Department of Pediatrics, College of Physicians and Surgeons of Columbia University, New York, New York, USA., Birkenbach KE; Naomi Berrie Diabetes Center & Division of Molecular Genetics, Department of Pediatrics, College of Physicians and Surgeons of Columbia University, New York, New York, USA., Engle SE; Department of Biology, Indiana University-Purdue University, Indianapolis, Indiana, USA., Tanis R; University of South Carolina School of Medicine, Columbia, South Carolina, USA., Levenson JM; University of Central Florida College of Medicine, Orlando, Florida, USA., Li X; Institute of Human Nutrition graduate program, Columbia University, New York, New York, USA., Rausch R; Naomi Berrie Diabetes Center & Division of Molecular Genetics, Department of Pediatrics, College of Physicians and Surgeons of Columbia University, New York, New York, USA., Purohit M; Zuckerman Institute, Columbia University, New York, New York, USA., Lee JY; Cancer Research Laboratory Molecular Imaging Center, University of California, Berkeley, 94720, USA., Tan J; Naomi Berrie Diabetes Center, Columbia Stem Cell Initiative, Department of Pathology and Cell Biology, Columbia University, New York, New York, USA., De Rosa MC; Naomi Berrie Diabetes Center, Columbia Stem Cell Initiative, Department of Pathology and Cell Biology, Columbia University, New York, New York, USA., Doege CA; Naomi Berrie Diabetes Center, Columbia Stem Cell Initiative, Department of Pathology and Cell Biology, Columbia University, New York, New York, USA., Aaron HL; Cancer Research Laboratory Molecular Imaging Center, University of California, Berkeley, 94720, USA., Martins GJ; Zuckerman Institute, Columbia University, New York, New York, USA., Brüning JC; Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany.; Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; National Center for Diabetes Research (DZD), Neuherberg, Germany., Egli D; Naomi Berrie Diabetes Center & Division of Molecular Genetics, Department of Pediatrics, College of Physicians and Surgeons of Columbia University, New York, New York, USA., Costa R; Zuckerman Institute, Columbia University, New York, New York, USA., Berbari N; Department of Biology, Indiana University-Purdue University, Indianapolis, Indiana, USA., Leibel RL; Naomi Berrie Diabetes Center & Division of Molecular Genetics, Department of Pediatrics, College of Physicians and Surgeons of Columbia University, New York, New York, USA., Stratigopoulos G; Naomi Berrie Diabetes Center & Division of Molecular Genetics, Department of Pediatrics, College of Physicians and Surgeons of Columbia University, New York, New York, USA.

Publikováno v: JCI insight [JCI Insight] 2019 Feb 07; Vol. 4 (3). Date of Electronic Publication: 2019 Feb 07.

Alkalinization potentiates vascular calcium deposition in an uremic milieu.

Autor: de Solis AJ; Laboratory of Nephrology and Hypertension, Jiménez Díaz-Capio Fundation, Universidad Autónoma de Madrid, Queen Sophie Renal Research Institute, Madrid, Spain., González-Pacheco FR, Deudero JJ, Neria F, Albalate M, Petkov V, Susanibar L, Fernandez-Sanchez R, Calabia O, Ortiz A, Caramelo C

Publikováno v: Journal of nephrology [J Nephrol] 2009 Sep-Oct; Vol. 22 (5), pp. 647-53.

[Response to hypoxia. A systemic mechanism based on the control of gene expression].

Autor: Caramelo C; Laboratorio de Nefrología e Hipertensión, Instituto de Investigaciones Médicas, Fundación Jiménez Díaz, Universidad Autónoma de Madrid., Peña Deudero JJ, Castilla A, Justo S, De Solis AJ, Neria F, Peñate S, Gonzalez-Pacheco FR

Publikováno v: Medicina [Medicina (B Aires)] 2006; Vol. 66 (2), pp. 155-64.